Finanzwire Finanzwire
Basculer en Français
11006 Companies
241133 Keywords
169708 Articles
129806 Press releases
Headlines Articles Press releases Viromed Medical AG Remove
  1. Home
  2. Companies
  3. Viromed Medical AG
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 04/22/2024 at 13:10, 2 years 4 months ago

    Viromed Medical AG Secures Exclusive Rights for Cold Plasma Therapy with CORIUS Group

    Medical Technology Earnings Growth Viromed Medical AG CORIUS Group Cold Plasma Therapy
  • PRESS RELEASE

    published on 04/22/2024 at 13:05, 2 years 4 months ago

    EQS-Adhoc: Viromed Medical AG concludes agreement with CORIUS Group for exclusive use of cold plasma therapy with Plasma Care® – Additional earnings contribution of EUR 0.28 to EUR 0.34 per share expected

    Viromed Medical AG partners with CORIUS Group for exclusive use of cold plasma therapy with Plasma Care®, expecting additional earnings contribution of EUR 0.28 to EUR 0.34 per share from 2025 onwards
    Earnings Contribution Viromed Medical AG CORIUS Group Cold Plasma Therapy Plasma Care®
    Logo of Viromed Medical AG
  • PRESS RELEASE

    published on 10/06/2023 at 09:05, 2 years 11 months ago

    Study proves: Cold plasma is a quantum leap for the treatment of chronic wounds

    Logo of Viromed Medical AG
Previous page
1 ... 11 12
Accesswire
  • Published on 09/16/2026 at 23:45, 6 hours 7 minutes ago

    Galway Metals Settles Claim by Former Employee with Cash and Share Payments

  • Published on 09/16/2026 at 21:30, 8 hours 22 minutes ago

    Torq Completes $1.7 Million Private Placement

  • Published on 09/16/2026 at 16:55, 12 hours 57 minutes ago

    CORRECTION FROM SOURCE: SLAM Reports 1.60% Copper Equivalent Over 14.45 Meters in Hole GW26-33; Trenching Gold-Antimony Targets on Moose Lake Project

  • Published on 09/16/2026 at 15:00, 14 hours 52 minutes ago

    2026 Canada's Top 40 Under 40(R) Honourees Announced

  • Published on 09/16/2026 at 14:00, 15 hours 52 minutes ago

    Ameriwest Awaits Bornite Core Assay Results and Provides Q3 2026 Corporate Update

View all ACCESSWIRE
EQS Group
  • Published on 09/17/2026 at 04:25, 1 hour 27 minutes ago

    Zhou Jianjun from Huawei: Building a Grid-Interactive AIDC Solution to Maximize Tokens Per Watt

  • Published on 09/16/2026 at 23:45, 6 hours 7 minutes ago

    WESCAN GOLDFIELDS COMMENCES UAV MAGNETIC AND LIDAR SURVEYS AT MUNRO LAKE PROJECT

  • Published on 09/16/2026 at 22:33, 7 hours 18 minutes ago

    EQS-Adhoc: Bilfinger adjusts outlook for 2026 and resolves program “Agile”

  • Published on 09/16/2026 at 21:15, 8 hours 37 minutes ago

    Gastech 2026 in Bangkok Converts Global Energy Ambition into Billions of Dollars in Deals

  • Published on 09/16/2026 at 20:27, 9 hours 24 minutes ago

    EQS-Adhoc: REPLOID Group AG resolves to issue convertible notes in an aggregate principal amount of up to EUR 30 million

View all EQS
Les Echos
  • Published on 09/16/2026 at 20:46, 9 hours 6 minutes ago

    LNA SANTE : 2026 First Half Results

  • Published on 09/16/2026 at 17:45, 12 hours 7 minutes ago

    5th edition of “On the way up” show

  • Published on 09/16/2026 at 17:45, 12 hours 7 minutes ago

    Report on share repurchases from 9 to 15 September 2026

  • Published on 09/16/2026 at 07:00, 22 hours 52 minutes ago

    bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification

  • Published on 09/15/2026 at 18:00, 1 day 11 hours ago

    Report on the Combined General Meeting of the 10th of September 2026

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy